AmSurg Corporation (AMSG)

AmSurg Corporation (AMSG - Analyst Report) is a leading operator of single-specialty practice-based ambulatory surgery centers (ASCs) in the U.S. The company recently reported net earnings from continuing operations of $12.862M (up 13% y/y) with EPS of $0.40 in-line with consensus estimates.

The quarter was characterized by a solid increase in procedure volume (up 9.5% y/y) despite essentially flat y/y same-store revenues, which reflected the impact of Medicare reimbursement cuts and the weaker economy. Nonetheless, the stock has been under further pressure given uncertainties related to healthcare reform and potential changes to Medicare.

We believe the stock has been oversold and move to a Buy recommendation at current levels. We have valued shares of AmSurg on a forward price/earnings (P/E) basis, as well as in comparison to similar firms in the healthcare facilities sector. Our $20 target price represents a multiple of 12x our FY09 EPS estimate of $1.66.

AmSurg Corporation (AMSG) : FULL ANALYST REPORT

Email	Print	Share	RSS	Rate Pos	Rate Neg	Comment

Loading Stories...

Related Content

RELATED ARTICLES BULL OF THE DAY ARCHIVE

Zacks Equity Research: Report For AM2&
N/A	12/01/09
Zacks Blog: AmSurg Beats Estimates Marginally
(AMSG)	10/23/09
Zacks Blog: AmSurg Moves into Oversold Territory
(AMSG)	07/10/09
Zacks Blog: Zacks Industry Rank Analysis Highlights: Healthsouth, Almost Family, AmSurg, DaVita, Emergency Medical Services, Genoptix and LHC Group.
(HLS, AFAM, AMSG, DVA, EMS, GXDX, LHCG)	05/13/09
Zacks Industry Rank Analysis: Good Numbers for Health Care Providers
(AMSG)	05/13/09

 Posting Comment...

There was a problem posting this this comment. Please try back later.
[CLICK TO CLOSE X]

Comments (Limit 1000 Characters - Used: 0)

Please provide your comments here... Display Name: Email Address:  

 Loading Comments...

Be the first to comment on this article!